CRISPR technology to cure sickle cell disease

University of Illinois Chicago is one of the U.S. sites participating in clinical trials to cure severe red blood congenital diseases such as sickle cell anemia or Thalassemia by safely modifying the DNA of patients' blood ...

A new nanomaterial for the war against counterfeits

Despite the anticounterfeiting devices attached to luxury handbags, marketable securities, and identification cards, counterfeit goods are on the rise. There is a demand for the next-generation anticounterfeiting technologies—that ...

Indigenous lands: A haven for wildlife

Indigenous peoples' lands may harbor a significant proportion of threatened and endangered species globally, according to University of Queensland-led research.

COVID-19 is dangerous for middle-aged adults, not just the elderly

COVID-19 has been spreading rapidly over the past several months, and the U.S. death toll has now reached 400,000. As evident from the age distribution of those fatalities, COVID-19 is dangerous not only for the elderly but ...

page 2 from 2